Sorafenib prescribed by gastroenterologists and hepatologists for hepatocellular carcinoma
Sign Up to like & getrecommendations! Published in 2018 at "Medicine"
DOI: 10.1097/md.0000000000009757
Abstract: Abstract Sorafenib is the only Food and Drug Administration (FDA)-approved first-line therapy shown to have survival benefit for patients with advanced hepatocellular carcinoma (HCC). Patients with advanced HCC are often but not exclusively transferred from… read more here.
Keywords: hepatocellular carcinoma; hcc; prescribed sorafenib; non oncologists ... See more keywords